Expression of mature pulmonary surfactant-associated protein B (SP-B) in Escherichia coli using truncated human SP-B cDNAs
- 1 February 1990
- journal article
- research article
- Published by Canadian Science Publishing in Biochemistry and Cell Biology
- Vol. 68 (2) , 559-566
- https://doi.org/10.1139/o90-080
Abstract
The present communication documents attempts to produce the mature form of human surfactant-associated protein B (SP-B) by modification of the 5′ and 3′ regions of the cDNA and expression of the truncated cDNAs after insertion into the vector pKK223-3. The 5′ end of a cDNA for human SP-B (1407 base pairs) was reconstructed through the ligation of synthetic oligonucleotides to an internal PstI site in the 5′ region. This construction coded for the initiation of protein synthesis at a Met codon adjacent to a codon for the N-terminal Phe of the mature polypeptide. Variable amounts of the 3′ end of the human SP-B cDNA were deleted with mung bean nuclease and exonuclease III. The resulting blunt-ended 3′ fragments were then ligated to a synthetic oligonucleotide linker designed to create a stop codon. The modified 5′ and 3′ ends were ligated to a short PstI-BamHI fragment isolated from the SP-B cDNA and inserted into the expression vector pKK223-3. In vitro translation of sense mRNAs derived from the truncated SP-B cDNAs yielded oligopeptides of appropriate molecular weights, as indicated by urea – sodium dodecyl sulphate –polyacrylamide gel electrophoresis of either intact or immunoprecipitated reaction mixtures. Expression of SP-B in Escherichia coli was confirmed by Northern blot analysis for the mRNAs corresponding to the truncated cDNAs in appropriately transformed bacteria induced with the galactose analog isopropyl-β-thiogalactoside. Western blot analysis using rabbit antisera prepared against bovine SP-B confirmed the presence of mature SP-B in lipid extracts of transformed E. coli, but the amounts were very small. These studies demonstrate the feasibility of producing mature human SP-B through recombinant DNA technology, but indicate that it may be necessary to use a fusion protein approach to obtain sufficient amounts for the formation of artificial pulmonary surfactant.Key words: pulmonary surfactant (human), hydrophobic proteins, artificial pulmonary surfactant, in vitro translation.This publication has 21 references indexed in Scilit:
- cDNA and deduced amino acid sequence of human pulmonary surfactant-associated proteolipid SPL(Phe).Proceedings of the National Academy of Sciences, 1987
- Nucleotide and amino acid sequences of pulmonary surfactant protein SP 18 and evidence for cooperation between SP 18 and SP 28-36 in surfactant lipid adsorption.Proceedings of the National Academy of Sciences, 1987
- Reconstitution of surfactant activity by using the 6 kDa apoprotein associated with pulmonary surfactantBiochemical Journal, 1986
- Proteolipid in bovine lung surfactant: Its role in surfactant functionBiochemical and Biophysical Research Communications, 1986
- Overproduction of fumarate reductase in Escherichia coli induces a novel intracellular lipid-protein organelleJournal of Bacteriology, 1984
- Vectors bearing a hybrid trp-lac promoter useful for regulated expression of cloned genes in Escherichia coliGene, 1983
- Cellular location affects protein stability in Escherichia coli.Proceedings of the National Academy of Sciences, 1982
- Experimental studies on the pulmonary surfactant. Reconstitution of surface-active material.Journal of Lipid Research, 1982
- Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.Proceedings of the National Academy of Sciences, 1979
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTJournal of Biological Chemistry, 1951